• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Sean Whooley

These ‘smart’ bandages could heal chronic wounds

February 18, 2020 By Sean Whooley

UConn biomedical engineers are touting a wirelessly controlled “smart” bandage and corresponding platform for delivering medications to chronic, non-healing wounds. UConn’s School of Dental Medicine, School of Medicine and School of Engineering comprise the biomedical engineering department, which contributed to developing the smart bandage. Ali Tamayol, an associate professor at UConn, led the development of […]

Filed Under: Drug-Device Combinations, Featured, Wound Care Tagged With: digital health, Harvard University, mobile health, UConn School of Medicine, universityofnebraska

Could this handheld 3D bioink printer improve wound healing?

February 14, 2020 By Sean Whooley

The University of Toronto is touting a new handheld 3D printer that is capable of depositing sheets of skin to cover burn wounds and accelerate the healing process. A study, led by Richard Cheng under the supervision of Axel Guenther, published in Biofabrication revealed that the 3D printer completed successful in-vivo trials on full-thickness wounds, […]

Filed Under: Featured, Wound Care Tagged With: University of Toronto

Wearable insulin delivery device maker Valeritas files for Chapter 11, selling company

February 12, 2020 By Sean Whooley

Valeritas (NSDQ:VLRX) announced that the company and its subsidiaries filed voluntary petitions for Chapter 11 bankruptcy, having agreed to sell substantially all of the business to Zealand Pharma (CPH:ZEAL). The agreement is slated to provide a total cash consideration of $23 million along with certain liabilities related to the ongoing business. Once the acquisition is completed, Zealand plans […]

Filed Under: Business/Financial News, Diabetes, Featured Tagged With: Valeritas Inc., Zealand Pharma

Senseonics, Companion Medical to integrate sensor glucose and insulin data

February 11, 2020 By Sean Whooley

Senseonics (NYSE:SENS) will integrate its Eversense continuous glucose monitoring (CGM) system’s real-time glucose data with Companion Medical‘s InPen smart insulin delivery system. The agreement between Senseonics and Companion, announced today, is slated to bring the technologies together to allow real-time glucose data to be continuously incorporated into the InPen insulin system. This is designed to allow for more […]

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: Companion Medical, Senseonics

Contura wins FDA premarket approval for hydrogel injection

February 4, 2020 By Sean Whooley

Contura announced that it won FDA premarket approval for its Bulkamid hydrogel injection for treating stress urinary incontinence (SUI). Bulkamid is Contura’s proprietary device designed for treating SUI due to intrinsic sphincter deficiency in adult women with SUI or stress predominant mixed incontinence. According to a news release, the product is currently marketed in more […]

Filed Under: Featured, Hydrogels, Women's Health Tagged With: Contura

Teleflex recalls certain Arrow epidural catheterization kits in Europe

February 4, 2020 By Sean Whooley

Teleflex

Teleflex  (NYSE:TFX) subsidiary Arrow issued an urgent field safety notice in Europe to warn of failures with the loss of resistance (LOR) syringes including in epidural catheterization kits. The company received complaints regarding the syringes in the kits that revealed dural puncture with some also requiring a blood patch. An inadvertent dural puncture may lead […]

Filed Under: Drug-Device Combinations, Featured, Recalls Tagged With: teleflex

Rani Therapeutics could go the IPO route

January 30, 2020 By Sean Whooley

Rani Therapeutics

Rani Therapeutics is reportedly moving forward with an early-stage efficacy and safety study for its robotic pills and may be on its way toward the possibility of an IPO. According to a report in Endpoints News, Rani, led by CEO Mir Imran who shared the story on LinkedIn, revealed that its RaniPill performed as expected […]

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup, Initial Public Offering (IPO) Tagged With: ranitherapeutics

Vascular Therapies closes $17.3m financing

January 29, 2020 By Sean Whooley

Vascular Therapies - updated logo

Vascular Therapies announced that it closed an upsized private funding round worth more than $17 million with contributions from new and existing investors. The Cresskill, N.J.–based clinical-stage biopharma company originally targeted $15 million for the financing, but finished with a total of $17.3 million raised. Get the full story at our sister site, MassDevice.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Funding Roundup Tagged With: vasculartherapies

Tandem Diabetes Care launches t:slim X2 with Control-IQ in U.S.

January 15, 2020 By Sean Whooley

Tandem Diabetes

Tandem Diabetes Care (NSDQ:TNDM) announced today that it began the U.S. commercial launch of its t:slim X2 insulin pump with Control-IQ advanced hybrid closed-loop technology. In December, the San Diego-based company announced that the FDA cleared the t:slim X2 insulin pump and Control-IQ technology for controlling Type 1 diabetes, touting it as the first and […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: artificial pancreas, Tandem Diabetes Care

7 medtech advances to improve diabetes treatment

January 10, 2020 By Sean Whooley

Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]

Pages: Page 1 Page 2

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Technology Tagged With: dariohealth, FDA, Medtronic, Novo Nordisk, One Drop, optiscanbiomedical, popsdiabetescare, Senseonics, Tandem Diabetes Care, Valeritas Inc.

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 71
  • Go to page 72
  • Go to page 73
  • Go to page 74
  • Go to page 75
  • Interim pages omitted …
  • Go to page 80
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS